| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | President & CEO, Director | Common Stock | 551K | $391K | $0.71 | Mar 16, 2022 | Direct |
| Generation Bio Co. | Director | Stock Option (right to buy) | 60K | $275K | $4.59 | Jun 6, 2024 | Direct |
| Aeglea BioTherapeutics, Inc. | President & CEO, Director | Common Stock | 266K | $189K | $0.71 | Mar 16, 2022 | By trusts |
| Generation Bio Co. | Director | Common Stock | 88.5K | $169K | $1.91 | Dec 1, 2023 | Direct |
| Generation Bio Co. | Director | Common Stock | 72.8K | $139K | $1.91 | Dec 1, 2023 | By Trust |
| Kaleido Biosciences, Inc. | Director | Stock Option (Right to Buy) | 15K | Jun 30, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| GBIO | Generation Bio Co. | Dec 1, 2023 | 1 | $125K | 4 | Dec 5, 2023 | Director |
| GBIO | Generation Bio Co. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| GBIO | Generation Bio Co. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Mar 16, 2022 | 1 | $188K | 4 | Mar 18, 2022 | President & CEO, Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Mar 11, 2022 | 3 | $281K | 4 | Mar 15, 2022 | President & CEO, Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Feb 17, 2022 | 1 | $0 | 4 | Feb 22, 2022 | President & CEO, Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Dec 31, 2021 | 8 | $0 | 5 | Feb 14, 2022 | President & CEO, Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Dec 9, 2021 | 2 | $199K | 4 | Dec 13, 2021 | President & CEO, Director |
| GBIO | Generation Bio Co. | Oct 28, 2021 | 2 | $0 | 4 | Oct 29, 2021 | Director |
| KLDO | Kaleido Biosciences, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
| GBIO | Generation Bio Co. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |